Immunohistochemical expression of TROP‑2 (TACSTD2) on the urothelial carcinoma of the urinary bladder and other types of cancerMahmoud Abbas, Katrin Schlack|Oncology Letters|2023Cited by 16
Breaking boundaries: Exploring extended pembrolizumab in first-line treatment of renal cell carcinoma with axitinib-pembrolizumab combinationC. Aydogdu, Jozefina Casuscelli, Rafał Stelmach et al.|European Urology|2024Cited by 0